Arch Biopartners Adds Three New Clinical Sites into the
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that...
Source: globenewswire.com
Stay updated with breaking news from Donna Senger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that...
07.02.2023 - TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) - Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting ...
Discovery opens the door to a potential new treatment for debilitating condition